FIELD: medicine.
SUBSTANCE: invention relates to composition of dexibuprofen syrup, including dexibuprophene ((S)-ibuprophene) with average particle size from 10 to 300 mcm as active ingredient, which does not contain glycerin and has viscosity from 500 to 300 cP and pH from 3.0 to 6.0.
EFFECT: increased safety, constant efficiency and improved taste.
6 cl, 34 ex, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL SUSPENSIONS, WHICH DO NOT CONTAIN COLOURING AGENTS, AND METHODS OF OBTAINING THEM | 2005 |
|
RU2395275C2 |
| CHEWING GUM CONTAINING ALLULOSE | 2016 |
|
RU2721237C1 |
| LIQUID COMPOSITIONS CONTAINING TASIMELTEON AND METHODS OF THEIR USE | 2020 |
|
RU2806302C1 |
| CONFECTIONARY PRODUCTS CONTAINING ALLULOSE | 2016 |
|
RU2727538C1 |
| SUSPENSION CONTAINING ALUMINUM HYDROXIDE AND MAGNESIUM HYDROXIDE AND METHOD FOR ITS PRODUCTION | 2018 |
|
RU2795006C2 |
| ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE | 1994 |
|
RU2150942C1 |
| PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSION OF GIVINOSTAT | 2016 |
|
RU2721396C2 |
| LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION, HAVING NOOTROPIC ACTIVITY | 2018 |
|
RU2703293C1 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| THIXOTROPIC PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2470627C2 |
